Epstein-Barr virus is related with 5-aminosalicylic acid, tonsillectomy, and CD19+ cells in Crohn’s disease

Figure 1 IgG anti-Epstein-Barr virus according to clinical scenarios in Crohn’s disease patients and healthy controls. New patient (n = 13), remission (n = 13), active disease (n = 10) and control (n = 36). P < 0.05 for new patient vs remission and controls. Values are expressed as mean ± SD.

Figure 2 Relationship between anti-Epstein-Barr virus IgG and B cells according to treatment in Crohn’s disease patients. Patients treated with 5-aminosalicylic acid (5-ASA) were significantly different from untreated patients (No) (Ps < 0.05). Values are expressed as mean ± SD.

Figure 3 Anti-Epstein-Barr virus IgG according to tonsillectomy in Crohn’s disease patients and controls. Tonsillectomized patients had significantly higher values; P < 0.05 for CD patients and all subjects. Values are expressed as mean ± SD. EBV: Epstein-Barr virus; CD: Crohn’s disease.